MS

Manjunath Sreenivasaiah

Director Director DIN 06559287
DIN 06559287 First appointment Apr 2013 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Manjunath Sreenivasaiah

Data last updated:

Manjunath Sreenivasaiah was a Director at Origin Innovations Private Limited (2013) and Director at Iqure Biomedical Systems Private Limited (from 2017). The companies operate in Professional Services.

DIN 06559287
Primary Designation Director
Industry Professional Services
First Appointment 22 Apr 2013
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Origin Innovations Private Limited U74140KA2013PTC068424
Director22 Apr 20132013Strike Off
Director23 Oct 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Iqure Biomedical Systems Private Limited
Origin Innovations Private Limited
Premium access

Shareholding and investment profile for Manjunath Sreenivasaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjunath Sreenivasaiah

Manjunath Sreenivasaiah was first appointed on 22 Apr 2013 as Director at Origin Innovations Private Limited. The most recent appointment on record is 23 Oct 2017 at Iqure Biomedical Systems Private Limited.

Manjunath Sreenivasaiah held 2 earlier board appointments: Origin Innovations Private Limited (Director, 22 Apr 2013 to 11 Oct 2013); Iqure Biomedical Systems Private Limited (Director, from 23 Oct 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available